| Authors | Satoshi Nakahara, Satoshi Fukushima, Etsuko Okada, Jun Morinaga, Yosuke Kubo, Aki Tokuzumi, Sayaka Matsumoto, Mina Tsuruta-Kadohisa, Toshihiro Kimura, Haruka Kuriyama, Azusa Miyashita, Ikko Kajihara, Masatoshi Jinnin, Hironobu Ihn |
| Journal | Journal of dermatological science
(J Dermatol Sci)
Vol. 97
Issue 1
Pg. 77-79
(Jan 2020)
ISSN: 1873-569X [Electronic] Netherlands |
| PMID | 31843231
(Publication Type: Letter)
|
| Chemical References |
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Immunological
- Biomarkers, Tumor
- Circulating MicroRNA
- PDCD1 protein, human
- Programmed Cell Death 1 Receptor
- Nivolumab
- pembrolizumab
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized
(pharmacology, therapeutic use)
- Antineoplastic Agents, Immunological
(pharmacology, therapeutic use)
- Biomarkers, Tumor
(blood, metabolism)
- Circulating MicroRNA
(blood, metabolism)
- Drug Resistance, Neoplasm
(genetics, immunology)
- Female
- Gene Expression Profiling
- Humans
- Male
- Melanoma
(blood, drug therapy, genetics, immunology)
- Middle Aged
- Nivolumab
(pharmacology, therapeutic use)
- Oligonucleotide Array Sequence Analysis
- Prognosis
- Programmed Cell Death 1 Receptor
(antagonists & inhibitors, immunology)
- Skin Neoplasms
(blood, drug therapy, genetics, immunology)
- Treatment Outcome
|
